| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |